80 related articles for article (PubMed ID: 35046711)
1. Identification of m6A-Associated Gene DST as a Prognostic and Immune-Associated Biomarker in Breast Cancer Patients.
Qiu X; Li X; Yan Y; Cai Y; Liang Q; Peng B; Xu Z; Xiao M; Xia F; Peng J
Int J Gen Med; 2022; 15():523-534. PubMed ID: 35046711
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive Analysis of the Associations of LOXL1-4 with Prognosis and Immune Infiltration in Breast Cancer.
He L; Lin Y; Huang P; Pan H
Altern Ther Health Med; 2024 Mar; ():. PubMed ID: 38518152
[TBL] [Abstract][Full Text] [Related]
3. Integrated Bioinformatics Analysis to Identify a Novel Four-Gene Prognostic Model of Breast Cancer and Reveal Its Association with Immune Infiltration.
Zhu Y; Luo J; Yang Y
Crit Rev Immunol; 2024; 44(2):1-14. PubMed ID: 38305332
[TBL] [Abstract][Full Text] [Related]
4. HTRA1 expression is associated with immune-cell infiltration and survival in breast cancer.
Zhao D; Li W; Wang Y; Zhang G; Bai X; Yu H
Transl Cancer Res; 2023 Dec; 12(12):3503-3521. PubMed ID: 38197075
[TBL] [Abstract][Full Text] [Related]
5.
Jin T; Park KS; Nam SE; Lim SH; Kim JH; Noh WC; Yoo YB; Park WS; Yun IJ
Ann Surg Treat Res; 2024 May; 106(5):263-273. PubMed ID: 38725802
[TBL] [Abstract][Full Text] [Related]
6. Identification of prognostic indicators, diagnostic markers, and possible therapeutic targets among LIM homeobox transcription factors in breast cancer.
Gao P; Sun N; Zhao T; Sun Y; Gu J; Ma D; Tian H; Peng Z; Zhang Y; Han F; Qi X
Cancer Innov; 2022 Oct; 1(3):252-269. PubMed ID: 38089759
[TBL] [Abstract][Full Text] [Related]
7. Identification of m6A-associated genes as prognostic and immune-associated biomarkers in Wilms tumor.
Zhuo Y; Zhang W; Du J; Jiang H; Chen G; Feng X; Gu H
Discov Oncol; 2023 Nov; 14(1):201. PubMed ID: 37938417
[TBL] [Abstract][Full Text] [Related]
8. A correlation study of adhesion G protein-coupled receptors as potential therapeutic targets for breast cancer.
Shi W; Xu C; Lei P; Sun X; Song M; Guo Y; Song W; Li Y; Yu L; Zhang H; Wang H; Zhang DL
Breast Cancer Res Treat; 2024 Jun; ():. PubMed ID: 38834774
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive analysis of the prognostic and immunological roles of HGH1 in breast cancer.
Ni Q; Xiang J; Liu J; Sun P
Asian J Surg; 2024 Jun; ():. PubMed ID: 38937228
[No Abstract] [Full Text] [Related]
10. Exploring PANoptosis in breast cancer based on scRNA-seq and bulk-seq.
He P; Ma Y; Wu Y; Zhou Q; Du H
Front Endocrinol (Lausanne); 2023; 14():1164930. PubMed ID: 37455906
[TBL] [Abstract][Full Text] [Related]
11. ELK3-CXCL16 axis determines natural killer cell cytotoxicity via the chemotactic activity of CXCL16 in triple negative breast cancer.
Jung HY; Lee DK; Lee M; Choi SH; Park JD; Ko ES; Lee J; Park KS; Jung HY
Oncoimmunology; 2023; 12(1):2190671. PubMed ID: 36950218
[TBL] [Abstract][Full Text] [Related]
12. Construction of a fatty acid metabolism-related gene signature for predicting prognosis and immune response in breast cancer.
Qian L; Liu YF; Lu SM; Yang JJ; Miao HJ; He X; Huang H; Zhang JG
Front Genet; 2023; 14():1002157. PubMed ID: 36936412
[No Abstract] [Full Text] [Related]
13. Construction of a DNA damage repair gene signature for predicting prognosis and immune response in breast cancer.
Chang Y; Huang Z; Quan H; Li H; Yang S; Song Y; Wang J; Yuan J; Wu C
Front Oncol; 2022; 12():1085632. PubMed ID: 36713553
[TBL] [Abstract][Full Text] [Related]
14. Single cell atlas identifies lipid-processing and immunomodulatory endothelial cells in healthy and malignant breast.
Geldhof V; de Rooij LPMH; Sokol L; Amersfoort J; De Schepper M; Rohlenova K; Hoste G; Vanderstichele A; Delsupehe AM; Isnaldi E; Dai N; Taverna F; Khan S; Truong AK; Teuwen LA; Richard F; Treps L; Smeets A; Nevelsteen I; Weynand B; Vinckier S; Schoonjans L; Kalucka J; Desmedt C; Neven P; Mazzone M; Floris G; Punie K; Dewerchin M; Eelen G; Wildiers H; Li X; Luo Y; Carmeliet P
Nat Commun; 2022 Sep; 13(1):5511. PubMed ID: 36127427
[TBL] [Abstract][Full Text] [Related]
15. PANoptosis-like cell death in ischemia/reperfusion injury of retinal neurons.
Yan WT; Zhao WJ; Hu XM; Ban XX; Ning WY; Wan H; Zhang Q; Xiong K
Neural Regen Res; 2023 Feb; 18(2):357-363. PubMed ID: 35900430
[TBL] [Abstract][Full Text] [Related]
16. Characterization of PANoptosis patterns predicts survival and immunotherapy response in gastric cancer.
Pan H; Pan J; Li P; Gao J
Clin Immunol; 2022 May; 238():109019. PubMed ID: 35470064
[TBL] [Abstract][Full Text] [Related]
17. Programmed Cell Death Tunes Tumor Immunity.
Liu J; Hong M; Li Y; Chen D; Wu Y; Hu Y
Front Immunol; 2022; 13():847345. PubMed ID: 35432318
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-200c Attenuates the Tumor-Infiltrating Capacity of Macrophages.
Raue R; Frank AC; Fuhrmann DC; de la Cruz-Ojeda P; Rösser S; Bauer R; Cardamone G; Weigert A; Syed SN; Schmid T; Brüne B
Biology (Basel); 2022 Feb; 11(3):. PubMed ID: 35336722
[TBL] [Abstract][Full Text] [Related]
19. The microbial metabolite trimethylamine N-oxide promotes antitumor immunity in triple-negative breast cancer.
Wang H; Rong X; Zhao G; Zhou Y; Xiao Y; Ma D; Jin X; Wu Y; Yan Y; Yang H; Zhou Y; Qian M; Niu C; Hu X; Li DQ; Liu Q; Wen Y; Jiang YZ; Zhao C; Shao ZM
Cell Metab; 2022 Apr; 34(4):581-594.e8. PubMed ID: 35278352
[TBL] [Abstract][Full Text] [Related]
20. Elevated expression of the rhythm gene NFIL3 promotes the progression of TNBC by activating NF-κB signaling through suppression of NFKBIA transcription.
Yang W; Li J; Zhang M; Yu H; Zhuang Y; Zhao L; Ren L; Gong J; Bi H; Zeng L; Xue Y; Yang J; Zhao Y; Wang S; Gao S; Fu Z; Li D; Zhang J; Wang T; Shan M; Tang B; Li X
J Exp Clin Cancer Res; 2022 Feb; 41(1):67. PubMed ID: 35180863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
